Do circulating Dipeptidyl peptidase 3 (cDPP3) plasma levels predict cardiogenic shock and mortality in patients with acute coronary syndromes?
Circulating DPP3 is a novel prognostic biomarker that improves early risk assessment for cardiogenic shock and mortality in patients with acute coronary syndromes.
This study identifies cDPP3 as a novel marker of CS and increased mortality in patients with ACS. Circulating DPP3 offers prognostic information beyond established risk factors and improves early risk assessment.
Wenzl et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: